|
2024
|
G/S
|
Health care services for treating cancer, namely cancer treatment targeting sortilin receptors |
|
|
Invention
|
Peptide conjugates of camptothecin analogs and uses thereof. DNA-damaging agents such as topoisom... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
lipodystrophy, obesity, wasting, growth hormone... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone ... |
|
2023
|
Invention
|
Drug conjugate compounds for stimulating the antitumor immune response. Despite significant progr... |
|
2022
|
G/S
|
Cancer treatment targeting sortilin receptors (term
considered too vague by the International Bu... |
|
|
Invention
|
Pharmaceutical compositions of ghrh analogs and uses thereof.
A pharmaceutical composition compr... |
|
|
G/S
|
Health care services for treating cancer, namely cancer treatment targeting sortilin receptors. |
|
|
Invention
|
Methods and sortilin binding conjugate compounds for targeting cancer stem cells.
The present ap... |
|
|
Invention
|
Methods and compounds for targeting cancer stem cells. The present application relates to methods... |
|
|
Invention
|
Methods and sortilin binding conjugate compounds for targeting cancer stem cells. The present app... |
|
2021
|
Invention
|
Low-dose pharmaceutical compositions of ghrh analogs and uses thereof.
A pharmaceutical composit... |
|
|
Invention
|
Low-dose pharmaceutical compositions of ghrh analogs and uses thereof. A pharmaceutical compositi... |
|
|
Invention
|
Low-dose pharmaceutical compositions of ghrh analogs and uses thereof. trans(1-44)2 trans(1-44)2e... |
|
2020
|
Invention
|
Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer.
The pre... |
|
|
Invention
|
Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer. The pres... |
|
|
Invention
|
Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer. 12345678... |
|
|
G/S
|
Providing information related to HIV.. |
|
|
G/S
|
Providing health information in the field of HIV |
|
|
G/S
|
Providing information related to HIV. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer.. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
2019
|
Invention
|
Pharmaceutical compositions of ghrh analogs and uses thereof. A pharmaceutical composition ... |
|
2016
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of HIV-1 infection |
|
2015
|
G/S
|
Pharmaceutical preparations for the treatment of lipodystrophy. Providing medical assistance and ... |
|
2014
|
Invention
|
Formulations of growth hormone releasing factor (grf) molecules with improved stability. Stabiliz... |
|
2013
|
Invention
|
Formulations of growth hormone releasing factor (grf) molecules with improved stability. 8, are a... |
|
2012
|
Invention
|
Peptide compounds derived from melanotransferrin and uses thereof. Peptide compounds derived from... |
|
|
Invention
|
Growth hormone releasing factor (grf) analogs and uses thereof. Growth Hormone-releasing Factor (... |
|
|
Invention
|
Growth hormone releasing factor (grf) analogs and uses thereof. Novel GRF analogs having GRF acti... |
|
|
Invention
|
Assessment of igf-1 levels in hiv-infected subjects and uses thereof.
Improved methods for deter... |
|
|
Invention
|
Assessment of igf-1 levels in hiv-infected subjects and uses thereof. Improved methods for determ... |
|
2011
|
Invention
|
Gh secretagogues and uses thereof.
The invention relates to use of a GH secretagogue (e.g. GRF o... |
|
|
Invention
|
Selection and treatment of patients suffering from wasting.
The invention relates to use of a GH... |
|
2010
|
Invention
|
Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy. A combination therap... |
|
|
Invention
|
Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy. A combination ther... |
|
|
Invention
|
Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy.
Combination t... |
|
2009
|
Invention
|
2α receptor. 2α receptor. The compositions include, but are not limited to, linear peptides, pept... |
|
2008
|
Invention
|
Gh secretagogues and uses thereof. The invention relates to use of a GH secretagogue (e.g. GRF or... |
|
|
Invention
|
Bifunctional hormone having alpha-msh activity and natriuretic peptide activity and uses thereof.... |
|
|
Invention
|
Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial n... |
|
|
Invention
|
Pharmaceutical formulations of ghrh molecules. Stabilized solid and liquid pharmaceutical formula... |
|
|
Invention
|
Pharmaceutical formulations of ghrh molecules.
Stabilized solid and liquid pharmaceutical formul... |
|
2007
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of lipodystrophy, obes... |
|
2006
|
Invention
|
Methods and compounds for prevention and treatment of elevated intraocular pressure and related c... |
|
2005
|
Invention
|
Modulators of blood glucose levels and uses thereof. Peptides are described, and methods and uses... |
|
|
Invention
|
Modulators of fatty acid-stimulated insulin secretion and uses thereof. Peptide compounds are des... |
|
|
Invention
|
Glucagon-like peptide-1 analogs with long duration of action. Novel GLP-1 analogs having improved... |
|
|
Invention
|
Glucagon-like peptide-1 analogs with long duration of action. Novel GLP-1 analogs having im... |
|
2004
|
Invention
|
Antagonistic peptides of prostaglandin e2 receptor subtype ep4.
wherein “X” is a hydrogen atom o... |
|
2002
|
Invention
|
2α receptor. 2αreceptor. The compositions include, but are not limited to, linear peptides, pepti... |
|
1998
|
G/S
|
Computer software for use in evaluating the quality of care and health services. |
